BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6147768)

  • 1. [Lithium in the treatment of periodically occurring catatonic arousal states in schizophrenic patients].
    Weizsäcker M; Wöller W; Tegeler J
    Nervenarzt; 1984 Jul; 55(7):382-4. PubMed ID: 6147768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Schizophrenic excitement and the role of lithium in its therapy (apropos of 2 recent cases)].
    Skurnik N; Shalev A; Munitz H; Tyano S
    Ann Med Psychol (Paris); 1985 Dec; 143(10):960-2. PubMed ID: 2873776
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-resistant catatonic stupor and combined lithium-neuroleptic therapy: a case report.
    Climo LH
    J Clin Psychopharmacol; 1985 Jun; 5(3):166-70. PubMed ID: 3923060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium in chronic schizophrenia.
    Growe GA; Crayton JW; Klass DB; Evans H; Strizich M
    Am J Psychiatry; 1979 Apr; 136(4A):454-5. PubMed ID: 34327
    [No Abstract]   [Full Text] [Related]  

  • 5. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of treating early-onset malignant schizophrenia with psychotropic drugs and their combinations].
    Sobolev ES; Zaĭtsev SG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(1):114-21. PubMed ID: 6111878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of gamma-vinyl GABA per os in 5 cases of hebephreno-catatonic schizophrenia].
    Lambert PA; Chabannnes JP; Cantiniaux P; Schechter PJ; Tell GP
    Encephale; 1983; 9(2):145-9. PubMed ID: 6641616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complex use of phenazepam, lithium and haloperidol in the treatment of several forms of schizophrenia].
    Mosketi KV; Mokhovikov AN; Aksent'ev SB; Goĭkhberg IG; Kryzhanovskiĭ GN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):589-96. PubMed ID: 6730829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of acatinol in the treatment of stable patients with schizophrenia with predominance of behaviour disorganization and subcatatonic features].
    Morozova MA; Rupchev GE; Kozhekin IG; Arsenieva TB; Cheremin RA; Yachmenev VN; Onegina EY; Shvedova AK; Beniashvili AG; Burminsky DS; Lepilkina TA; Potanin SS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(1):35-41. PubMed ID: 24637815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
    Dursun SM; Hallak JE; Haddad P; Leahy A; Byrne A; Strickland PL; Anderson IM; Zuardi AW; Deakin JF
    J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003
    [No Abstract]   [Full Text] [Related]  

  • 11. [The place of pyrogen therapy in the modern treatment of schizophrenia patients].
    Malin DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1992; 92(3):81-5. PubMed ID: 1332338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative motor activity differentiates schizophrenia subtypes.
    Walther S; Horn H; Razavi N; Koschorke P; Müller TJ; Strik W
    Neuropsychobiology; 2009; 60(2):80-6. PubMed ID: 19752582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in the treatment of catatonia in a schizophrenic patient.
    Poyurousky M; Bergman J; Weizman A
    Isr J Psychiatry Relat Sci; 1997; 34(4):323-4. PubMed ID: 9409090
    [No Abstract]   [Full Text] [Related]  

  • 14. Antipsychotic effects of lithium in schizophrenia.
    Alexander PE; van Kammen DP; Bunney WE
    Am J Psychiatry; 1979 Mar; 136(3):283-7. PubMed ID: 369396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacologic management of behavior sequelae in head injury: a case report.
    Haas JF; Cope DN
    Arch Phys Med Rehabil; 1985 Jul; 66(7):472-4. PubMed ID: 2861801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful Treatment With Lithium in a Refractory Patient With Periodic Catatonic Features: A Case Report.
    Sato Y; Shinozaki M; Okayasu H; Yasui-Furukori N; Shimoda K
    Clin Neuropharmacol; 2020; 43(3):84-85. PubMed ID: 32384310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Managing agitation in acute psychotic episodes of schizophrenia].
    Thomas P
    Encephale; 2006 Jan; 32 Pt 2():S12-3. PubMed ID: 16800080
    [No Abstract]   [Full Text] [Related]  

  • 18. [Severe hypernatremia within the scope of catatonic schizophrenia].
    Trabert W; von Blohn G; Gawlitza M
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):196-8. PubMed ID: 2873092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptics: use in states of agitation].
    Dufour H; Tramoni AV; Colonne C
    Rev Prat; 1984 Mar; 34(13):597-8, 601-5. PubMed ID: 6143386
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraindividual comparison of the effect of perphenazine and of the combination of perphenazine and lithium in schizophrenia.
    Rysánek R; Cesková E; Svestka J; Náhunek K
    Act Nerv Super (Praha); 1989 Apr; 31(1):37-8. PubMed ID: 2571222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.